| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO
2 companies
Longenecker John P Phd is a Director at Pacira BioSciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 4 sells.
Estimated insider holdings value: $437K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 7,000 | $71.74 | $502,145.00 | -27.1% | -11.4% | -41.3% | |
| Mar 1, 2021 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 5,000 | $72.26 | $361,300.00 | -22.0% | - | - | |
| Dec 2, 2019 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 1,300 | $46.13 | $59,971.60 | -9.2% | - | - | |
| Aug 10, 2018 | RNTX Rein Therapeutics, Inc. | President And CEO | Buy | 10,000 | $2.45 | $24,500.00 | New | - | - | |
| Jan 12, 2016 | PCRX Pacira Biosciences, Inc. | Director | Buy | 300 | $66.55 | $19,964.70 | +15.0% | - | - | |
| Mar 12, 2015 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 3,000 | $95.28 | $285,840.00 | -100% | - | - |